Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,259 | 56 | 99.1% |
| Education | $11.56 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $296.42 | 5 | $0 (2021) |
| GlaxoSmithKline, LLC. | $273.46 | 17 | $0 (2021) |
| Philips Electronics North America Corporation | $86.76 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $85.60 | 4 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $46.23 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $43.04 | 2 | $0 (2020) |
| Electromed, Inc. | $41.98 | 3 | $0 (2023) |
| Shire North American Group Inc | $37.08 | 2 | $0 (2017) |
| Stryker Corporation | $35.71 | 1 | $0 (2021) |
| Ethicon Inc. | $34.22 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.93 | 1 | Philips North America LLC ($17.93) |
| 2023 | $19.30 | 1 | Electromed, Inc. ($19.30) |
| 2022 | $51.43 | 3 | Ambu Inc. ($23.46) |
| 2021 | $403.64 | 9 | AstraZeneca Pharmaceuticals LP ($260.02) |
| 2020 | $188.14 | 10 | GlaxoSmithKline, LLC. ($101.35) |
| 2019 | $223.49 | 14 | GlaxoSmithKline, LLC. ($102.17) |
| 2018 | $119.20 | 4 | Philips Electronics North America Corporation ($74.59) |
| 2017 | $247.21 | 15 | Shire North American Group Inc ($37.08) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: Medical Device | ||||||
| 03/30/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: HFCWO | ||||||
| 11/24/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| 06/02/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $12.17 | General |
| Category: Medical Device | ||||||
| 02/17/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 12/16/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $126.55 | General |
| Category: Respiratory | ||||||
| 12/01/2021 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VTE | ||||||
| 10/05/2021 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: Endo-Mechanical | ||||||
| 07/14/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2021 | Stryker Corporation | PREVALON (Device) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: MEDICAL | ||||||
| 04/26/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.91 | General |
| Category: Respiratory | ||||||
| 02/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 12/30/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2020 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Cardio-pulmonary | ||||||
| 05/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 238 | 390 | $189,512 | $47,719 |
| 2022 | 7 | 196 | 351 | $201,498 | $43,528 |
| 2021 | 12 | 380 | 546 | $202,161 | $46,386 |
| 2020 | 11 | 334 | 498 | $241,666 | $56,336 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 68 | 171 | $115,610 | $28,513 | 24.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 110 | $38,297 | $9,991 | 26.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 56 | $13,076 | $3,483 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $10,704 | $2,727 | 25.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 15 | 20 | $6,721 | $1,676 | 24.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,104 | $1,330 | 26.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 70 | 172 | $138,460 | $28,698 | 20.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 46 | 86 | $25,886 | $6,945 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 40 | $8,400 | $2,154 | 25.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $6,468 | $1,717 | 26.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 15 | 18 | $6,480 | $1,553 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $5,200 | $1,385 | 26.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 11 | 11 | $10,604 | $1,076 | 10.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 52 | 149 | $119,945 | $25,908 | 21.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 77 | $23,177 | $6,168 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 48 | $16,554 | $4,526 | 27.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 37 | $9,078 | $2,631 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 43 | $9,030 | $2,460 | 27.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 13 | $6,236 | $1,847 | 29.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 12 | 12 | $11,568 | $1,215 | 10.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 47 | 58 | $1,508 | $386.86 | 25.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 14 | 14 | $1,540 | $310.83 | 20.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 28 | 28 | $1,036 | $272.72 | 26.3% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 11 | 11 | $1,089 | $272.68 | 25.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 28 | 28 | $700.00 | $202.16 | 28.9% |
About Dr. Amber Degryse, MD
Dr. Amber Degryse, MD is a Specialist healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447307236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amber Degryse, MD has received a total of $1,270 in payments from pharmaceutical and medical device companies, with $17.93 received in 2024. These payments were reported across 57 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,259).
As a Medicare-enrolled provider, Degryse has provided services to 1,148 Medicare beneficiaries, totaling 1,785 services with total Medicare billing of $193,969. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Pulmonary Disease
- Location Atlanta, GA
- Active Since 01/04/2007
- Last Updated 04/26/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1447307236
Products in Payments
- FASENRA (Biological) $248.46
- NUCALA (Biological) $112.18
- Wellcentive Undiv (Device) $74.59
- BREO (Drug) $46.77
- ANORO (Drug) $46.57
- Adempas (Drug) $46.23
- SPIRIVA RESPIMAT (Drug) $42.62
- SMARTVEST (Device) $41.98
- ANORO ELLIPTA (Drug) $39.64
- GLASSIA (Biological) $37.08
- PREVALON (Device) $35.71
- Monarch Platform (Device) $34.22
- TRELEGY ELLIPTA (Drug) $28.30
- The Vest System Model 105 Home Care (Device) $27.91
- RAYOS (Drug) $24.54
- STIOLTO RESPIMAT (Drug) $23.74
- FASENRA (Drug) $21.63
- XOLAIR (Biological) $21.61
- ENTRESTO (Drug) $21.43
- OFEV (Drug) $19.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlanta
Melhem Solh, M.d, M.D
Specialist — Payments: $1.1M
Sumayah Taliaferro, Md, MD
Specialist — Payments: $98,474
Theresa Jarmuz, M.d, M.D
Specialist — Payments: $98,072
Dr. Scott Solomon, M.d, M.D
Specialist — Payments: $59,894
Dr. Asad Bashey, M.d, M.D
Specialist — Payments: $45,487
Dr. Bronier Costas, M.d, M.D
Specialist — Payments: $45,325